Trial Profile
A randomized, open-label, 4-way study to study the effects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Tiotropium bromide (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Nov 2015 New trial record